Updated version of this database is available at ThpDB2

Browse result page of THPdb

The total number entries retrieved from this search are 159
ID1029ThPPIDTh1005NameEtanerceptPeptide SequenceLPAQVAFTPYAPEPGSTCRL Full viewLength255Functional ClassificationIIaDiseaseImmunologicalBrandEnbrel SureclickCompanyN.A.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1033ThPPIDTh1006NameBivalirudinPeptide SequenceFPRPGGGGNGDFEEIPEEYL Full viewLength20Functional ClassificationIaDiseaseHematological,MetabolicBrandAngioxCompanyThe Medicines Company UK LtdPhysical AppearancePowder for concentrate for solutionRoute of AdministartionInjectionCategoryAntithrombins TargetProthrombin
ID1039ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandEnantoneCompanyTakedaPhysical AppearanceSolutionRoute of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1049ThPPIDTh1008NamePeginterferon alfa-2aPeptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseImmunologicalBrandPegasysCompanyHoffman-La Roche IncPhysical AppearanceSterile, preservative-free, colorless to light yellow injectable solutionRoute of AdministartionSubcutaneous InjectionCategoryImmunosuppressive Agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1059ThPPIDTh1010NameInterferon alfa-n1Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseInfectious /ImmunologicalBrandWellferonCompanyGlaxoSmithKlinePhysical AppearanceSolutionRoute of AdministartionInjectionCategoryAntiviral Agents, Immunologic factors, Immunosuppressiv agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1064ThPPIDTh1011NameDarbepoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandAranespCompanyAmgen IncPhysical AppearanceSterile, colorless, preservative-free solution containing polysorbateRoute of AdministartionIntravenousor Subcutaneous administrationCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1071ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandBinocritCompanySandozPhysical AppearanceClear colourless solutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1076ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandEprexCompanyJanssen-Cilag. Ortho Biologics LLCPhysical AppearanceSolutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1077ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandNanokineCompanyNanogen Pharmaceutical biotechnology, Vietnam)Physical AppearanceSterile, white, lyophilized powder. The reconstituted preparation with 1 ml solvent (containing 0.9% benzyl alcohol) results in a clear, colorless solution.Route of AdministartionInjectionCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1078ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandProcritCompanyOrtho BiotechPhysical AppearanceSterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solutionRoute of AdministartionIntravenous(IV) or Subcutaneous (SC) administration.CategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1098ThPPIDTh1014NameSalmon CalcitoninPeptide SequenceCSNLSTCVLGKLSQELHKLQ Full viewLength32Functional ClassificationIbDiseaseOsteologicalBrandCalcimarCompanyN.A.Physical AppearanceSolutionRoute of AdministartionSubcutaneous or Intramuscular InjectionCategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents TargetCalcitonin receptor
ID1100ThPPIDTh1014NameSalmon CalcitoninPeptide SequenceCSNLSTCVLGKLSQELHKLQ Full viewLength32Functional ClassificationIbDiseaseOsteologicalBrandMiacalcinCompanyNovartisPhysical AppearanceSolutionRoute of AdministartionSubcutaneous or Intramuscular InjectionCategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents TargetCalcitonin receptor
ID1110ThPPIDTh1015NameInterferon alfa-n3Peptide SequenceAlpha-2A:CDLPQTHSLG< Full viewLength235Functional ClassificationIbDiseaseImmunologicalBrandAlferonCompanyInterferon Sciences Inc.Physical AppearanceSolutionRoute of AdministartionInjectionCategoryImmunosuppressive Agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1117ThPPIDTh1016NamePegfilgrastimPeptide SequenceMTPLGPASSLPQSFLLKCLE Full viewLength175Functional ClassificationIbDiseaseImmunologicalBrandNeulastaCompanyAmgen Inc.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents, Anti-neutropenic agents TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase
ID1120ThPPIDTh1017NameSargramostimPeptide SequenceAPARSPSPSTQPWEHVNAIQ Full viewLength127Functional ClassificationIbDiseaseImmunologicalBrandLeucomaxCompanyNovartisPhysical AppearanceSolutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryImmunosuppressive Agents TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1121ThPPIDTh1017NameSargramostimPeptide SequenceAPARSPSPSTQPWEHVNAIQ Full viewLength127Functional ClassificationIbDiseaseImmunologicalBrandLeukineCompanyBerlex Laboratories IncPhysical AppearanceSterile, preserved (1.1% benzyl alcohol), injectable solution (500 mcg/mL) and also as sterile, white, preservative free lyophilized powder (250 mcg) that requires reconstitution with 1 mL sterile water for InjectionRoute of AdministartionSubcutaneous Injection (SC) or Intravenous infusion (IV)CategoryImmunosuppressive Agents TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1130ThPPIDTh1018NameSecretinPeptide SequenceHSDGTFTSELSRLRDSARLQ Full viewLength27Functional ClassificationIVDiseaseHormonal disordersBrandSecremaxCompanyRepligen CorpPhysical AppearanceSolutionRoute of AdministartionIntravenousCategoryDiagnostic Agents TargetSecretin receptor
ID1157ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandMonoclate-PCompanyN.A.Physical AppearanceLyophilized powder for solutionRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1180ThPPIDTh1023NameAnakinraPeptide SequenceMRPSGRKSSKMQAFRIWDVN Full viewLength153Functional ClassificationIIaDiseaseImmunologicalBrandKineretCompanyAmgen IncPhysical AppearanceSterile, clear, colorless-to-white, preservative free solutionRoute of AdministartionSubcutaneous (SC) administrationCategoryImmunosuppressive Agents, Anti-rheumatic agents TargetInterleukin-1 receptor type 1
ID1188ThPPIDTh1024NameGramicidin DPeptide SequenceVGALAVVVWLWLWLWX Full viewLength16Functional ClassificationIIaDiseaseInfectiousBrandSofradexCompanySanofiPhysical AppearanceSterile, clear, bright, colourless, aqueous solutionRoute of AdministartionAuricular and Ocular use.CategoryAnti-Bacterial Agents, Anti-infective, Topical, Antibiotic TargetN.A.
ID1195ThPPIDTh1025NameIntravenous ImmunoglobulinPeptide SequenceIGG1:PSALTQPPSASGSLG Full viewLength250Functional ClassificationIaDiseaseImmunologicalBrandGamunexCompanyTalecris BiotherapeuticsPhysical AppearanceSterile solutionRoute of AdministartionIntravenous infusionCategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1205ThPPIDTh1027NameInsulin RegularPeptide SequenceA-chain:GIVEQCCTSIC< Full viewLength51Functional ClassificationIaDiseaseGenetic/HormonalBrandHumulin RCompanyEli Lilly and CompanyPhysical AppearanceSterile, clear, aqueous, and colorless solutionRoute of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision.CategoryAntidiabetic Agents TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1206ThPPIDTh1027NameInsulin RegularPeptide SequenceA-chain:GIVEQCCTSIC< Full viewLength51Functional ClassificationIaDiseaseGenetic/HormonalBrandNovolin RCompanyNovo NordiskPhysical AppearanceSterile, clear, aqueous, and colorless solutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryAntidiabetic Agents TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1226ThPPIDTh1030NameInterferon gamma-1bPeptide SequenceCYCQDPYVKEAENLKKYFNA Full viewLength146Functional ClassificationIbDiseaseImmunologicalBrandActimmuneCompanyInterMune IncPhysical AppearanceSterile, clear, colorless solutionRoute of AdministartionSubcutaneous InjectionCategoryImmunosuppressive Agents TargetInterferon gamma receptor 1,Interferon gamma receptor 2
ID1229ThPPIDTh1031NameInterferon Alfa-2a, RecombinantPeptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseImmunologicalBrandRoferon ACompanyHoffmann-La Roche IncPhysical AppearanceSolutionRoute of AdministartionSubcutaneous InjectionCategoryN.A. TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1260ThPPIDTh1037NameBotulinum Toxin Type BPeptide SequenceMPVTINNFNYNDPIDNNNII Full viewLength255Functional ClassificationIcDiseaseNeurological DisorderBrandMyoblocCompanySolstice NeurosciencesPhysical AppearanceClear and colorless to light-yellow sterile injectable solutionRoute of AdministartionInjectionCategoryAntidystonic Agents TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
ID1261ThPPIDTh1037NameBotulinum Toxin Type BPeptide SequenceMPVTINNFNYNDPIDNNNII Full viewLength255Functional ClassificationIcDiseaseNeurological DisorderBrandNeuroblocCompanySolstice NeurosciencesPhysical AppearanceClear and colourless to light yellow solutionRoute of AdministartionIntramuscular InjectionCategoryAntidystonic Agents TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
ID1269ThPPIDTh1039NameLutropin alfaPeptide SequenceAlpha Chain: APDVQDC Full viewLength213Functional ClassificationIbDiseaseHormonalBrandLuverisCompanySeronoPhysical AppearanceWhite lyophilised pellet withg clear colourless solvent to make solutionRoute of AdministartionSubcutaneous (SC) administrationCategoryFertility Agents TargetLutropin-choriogonadotropic hormone receptor
ID1275ThPPIDTh1040NameInsulin LisproPeptide SequenceA chain:GIVEQCCTSICS Full viewLength51Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandHumalogCompanyEli LillyPhysical AppearanceSterile, aqueous, clear, and colorless solutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1276ThPPIDTh1040NameInsulin LisproPeptide SequenceA chain:GIVEQCCTSICS Full viewLength51Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandHumalog KwikPenCompanyEli LillyPhysical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1283ThPPIDTh1041NameInsulin GlarginePeptide SequenceA-chain:GIVEQCCTSICS Full viewLength53Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandLantusCompanySanofi-AventisPhysical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1284ThPPIDTh1041NameInsulin GlarginePeptide SequenceA-chain:GIVEQCCTSICS Full viewLength53Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandLantus OptiSetCompanyN.A.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1285ThPPIDTh1041NameInsulin GlarginePeptide SequenceA-chain:GIVEQCCTSICS Full viewLength53Functional ClassificationIaDiseaseHormonal/Metabolic/geneticBrandLantus SoloStarCompanyN.A.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryHypoglycemic Agents, Antidiabetic agents TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1306ThPPIDTh1043NameRasburicasePeptide SequenceSAVKAARYGKDNVRVYKVHK Full viewLength255Functional ClassificationIcDiseaseMetabolic/GeneticBrandFasturtecCompanyN.A.Physical AppearancePowder and solvent that are made upto make solution.Route of AdministartionIntravenous administartionCategoryAntihyperuricemic Agents, Gout suppressants TargetUric acid
ID1316ThPPIDTh1044NameAdalimumabPeptide SequenceLight-chain:DIQMTQS< Full viewLength230Functional ClassificationIcDiseaseImmunologicalBrandHumiraCompanyAbbott LaboratoriesPhysical AppearanceSterile, preservative-free solutionRoute of AdministartionSubcutaneous administrationCategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1317ThPPIDTh1044NameAdalimumabPeptide SequenceLight-chain:DIQMTQS< Full viewLength230Functional ClassificationIcDiseaseOsteologicalBrandHumira PenCompanyAbbott LaboratoriesPhysical AppearanceSterile, preservative-free solutionRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1327ThPPIDTh1046NameAbciximabPeptide SequenceH ReoPro-like antibo Full viewLength218Functional ClassificationIIaDiseaseGenetic/Metabolic/HaemetologicalBrandReoProCompanyEli Lilly and CompanyPhysical AppearanceClear, colorless, sterile, non-pyrogenic solutionRoute of AdministartionIntravenous administartionCategoryPlatelet Aggregation Inhibitors, Anticoagulants TargetIntegrin beta-3,Integrin alpha-IIb,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immuno
ID1337ThPPIDTh1048NamePegaspargasePeptide SequenceMEFFKKTALAALVMGFSGAA Full viewLength255Functional ClassificationIcDiseaseCancerBrandOncasparCompanyEnzon IncPhysical AppearanceSolutionRoute of AdministartionIntravenous or Intramuscular administrationCategoryAntineoplastic Agents TargetL-asparagine
ID1342ThPPIDTh1049NameInterferon beta-1aPeptide SequenceMSYNLLGFLQRSSNFQCQKL Full viewLength166Functional ClassificationIbDiseaseCancer/Infectious/ImmunologicalBrandBetaferonCompanyBayerPhysical AppearancePowder and solvent that are made upto make solution.Route of AdministartionSubcutaneous InjectionCategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1346ThPPIDTh1049NameInterferon beta-1aPeptide SequenceMSYNLLGFLQRSSNFQCQKL Full viewLength166Functional ClassificationIbDiseaseCancer/Infectious/ImmunologicalBrandRebifCompanyMerckPhysical AppearanceSterile solution in a prefilled syringe or REBIF Rebidose autoinjectorRoute of AdministartionSubcutaneous InjectionCategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1358ThPPIDTh1050NamePegademase bovinePeptide SequenceMAQTPAFNKPKVELHVHLDG Full viewLength255Functional ClassificationIaDiseaseMetabolicBrandAdagenCompanyEnzon Inc.Physical AppearanceIsotonic, pyrogen free, sterile solution, pH 7.2-7.4Route of AdministartionIntramusular InjectionCategoryEnzyme Replacement Agents TargetAdenosine,Growth factor receptor-bound protein 2
ID1361ThPPIDTh1051NameHuman Serum AlbuminPeptide SequenceMKWVTFISLLFLFSSAYSRG Full viewLength609Functional ClassificationIaDiseaseHematological/Metabolic/geneticBrandAlbuminarCompanyCSL BehringPhysical AppearanceSterile aqueous solution of albumin obtained from large pools of adult human venous plasma by low temperature controlled fractionation according to the Cohn process.Route of AdministartionAlbumin (Human) 25%, Albuminar-25 (albumin human) , is to be administered by the Intravenous route.CategorySerum substitutes TargetN.A.
ID1362ThPPIDTh1051NameHuman Serum AlbuminPeptide SequenceMKWVTFISLLFLFSSAYSRG Full viewLength609Functional ClassificationIaDiseaseHematological/Metabolic/geneticBrandAlbuteinCompanyGRIFOLSPhysical AppearanceSterile, aqueous solution for single dose intravenous administration containing 20% human albumin (weight/volume).Route of AdministartionAlbutein 20% is to be administered by the Intravenous route.CategorySerum substitutes TargetN.A.
ID1363ThPPIDTh1052NameEptifibatidePeptide SequenceMpr-Har-Gly-Asp-Trp- Full viewLength7Functional ClassificationIbDiseaseHematological/MetabolicBrandINTEGRILINCompanySchering-Plough/EssexPhysical AppearanceClear, colorless, sterile, non-pyrogenic solution  of EptifibatideRoute of AdministartionInjection Solution for IIntravenousUseCategoryPlatelet Aggregation Inhibitors TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor
ID1365ThPPIDTh1053NameSerum albumin iodonatedPeptide SequenceMKWVTFISLLFLFSSAYSRG Full viewLength600Functional ClassificationIVDiseaseHematological DisordersBrandMegatopeCompanyIsoTex DiagnosticsPhysical AppearanceColorless to very pale yellow solutionsRoute of AdministartionInjection for Intravenous administrationCategoryDiagnostic Agents TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP
ID1366ThPPIDTh1053NameSerum albumin iodonatedPeptide SequenceMKWVTFISLLFLFSSAYSRG Full viewLength600Functional ClassificationIVDiseaseHematological DisordersBrandJeanotopeCompanyIsoTex DiagnosticsPhysical AppearanceSterile, nonpyrogenic, aqueos solutionRoute of AdministartionIntravenous infusionCategoryDiagnostic Agents TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP
ID1372ThPPIDTh1055NameFollitropin betaPeptide SequenceA Chain: APDVQDCPECT Full viewLength204Functional ClassificationIbDiseaseHormonal disordersBrandFollistim AQCompanyMerckPhysical AppearanceSterile aqueous solution Route of AdministartionSubcutaneous or Intramuscular administrationCategoryFertility Agents TargetFollicle-stimulating hormone receptor
ID1375ThPPIDTh1056NameVasopressinPeptide SequenceCYFQNCPRG
Full view
Length9Functional ClassificationIbDiseaseHormonalBrandPitressinCompanyJHP PharmaceuticalsPhysical AppearanceSterile, aqueous solution of synthetic vasopressinRoute of AdministartionIntramuscular or Subcutaneous useCategoryAntidiuretic Agents TargetVasopressin V2 receptor,Vasopressin V1a receptor,Vasopressin V1b receptor
ID1377ThPPIDTh1057NameInterferon beta-1bPeptide SequenceMSYNLLGFLQRSSNFQSQKL Full viewLength166Functional ClassificationIbDiseaseImmunologicalBrandBetaferonCompanyBayerPhysical AppearancePowder and solvent that are made upto make solution.Route of AdministartionSubcutaneous InjectionCategoryAdjuvants, Immunologic and Immunosuppressive Agents TargetN.A.
ID1381ThPPIDTh1059NameHyaluronidasePeptide SequenceMWTGLGPAVTLALVLVVAWA Full viewLength476Functional ClassificationIcDiseaseAdjunct TherapyBrandHYLENEXCompanyBaxter Healthcare CorporationPhysical AppearanceSterile, clear, colorless, nonpreserved, ready for use solution.Route of AdministartionHuman Injection Subcutaneous useCategoryAdjuvants, Anesthesia and Permeabilizing Agents TargetN.A.